Vitura raises $5.1 million from Charlie Shahin AO
Filed with ASX · · 3 pages · English
Summary by 6ix AI
The company issued a substantial number of ordinary shares at a discount to the market price, resulting in a notable increase in its capital. The funds will primarily be used for the acquisition of Candor Medical and to support future expansion plans. Vitura's Chair expressed confidence in the strategic partnership with Shahin, highlighting his experience as a valuable asset for the company's growth.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Vitura Health
- Trading Halt
- Update regarding TGA proceedings
- Vitura JV acquires assets of Releaf Group
- Strategy Reset delivers positive Q1 results
- Vitura settles dispute with Code4 Cannabis
Later from Vitura Health
- Vitura acquires Candor Medical
- Vitura completes acquisition of Candor Medical
- Appendix 4D
- H1 FY2025 financial results
- Vitura completes acquisition of Canview platform
Follow Vitura Health into a list and get an email when it puts out news.
Follow Vitura Health